![]() |
市场调查报告书
商品编码
1371875
到 2030 年医疗影像影像市场预测:按部署模式、解决方案、技术、影像模式、用途、最终用户和地区进行的全球分析Artificial Intelligence in Medical Imaging Market Forecasts to 2030 - Global Analysis By Deployment Mode, Solution, Technology (Deep Learning, Natural Language Processing and Other Technologies), Imaging Mode, Application, End User and By Geography |
根据Stratistics MRC预测,2023年全球医疗影像诊断领域人工智慧(AI)市场规模将达到17.7亿美元,预测期内年复合成长率为28.5%,到2030年将达到102.5亿美元。预计将达到。
医学影像处理中的人工智慧(AI)是指将人工智慧技术应用于各种显像模式,例如超音波、电脑断层扫描(CT)、磁振造影(MRI)和X射线,以改善医学影像的处理. - 指自动化。使用先进的演算法和机器学习模型从医学影像中分析和提取重要资讯,以帮助识别、诊断和治疗各种疾病和状况。
根据美国癌症协会总合,今年美国将新增 236,740 例肺癌和支气管癌罹患。
目前的医学影像处理市场是由人工智慧驱动的。这是因为该软体的好处是可以让医生更快诊断疾病并提供早期疗育。此外,新的人工智慧主导新兴企业正在专注于人工智慧医疗影像解决方案并添加复杂的功能。推进医学影像处理领域的人工智慧还需要增加该领域的资金和投资。例如,立陶宛的 oxipit.ai 于 2023 年 1 月筹集了 490 万美元资金,用于开发完全自主的 AI医疗图像并拓展新地区的市场。因此,全球人工智慧主导的新兴企业数量不断增加,以及用于开发完全自主的人工智慧医学影像处理工具的资金筹措不断增加,正在推动市场成长。
市场成长受到医学影像样本和其他诊断多种疾病的设备中使用的各种人工智慧技术成本高昂的限制。目前,低度开发国家和开发中国家的大多数医院和研究机构无法承担医学影像处理人工智慧研究的高额成本。因此,这些要素阻碍了市场的成长。
先进的人工智慧工具和技术预计将在未来年度彻底改变医疗保健和放射行业。目前涉足医疗影像处理产业AI的企业预测,AI在医疗领域尤其是放射科领域的引进,将带来广泛的机会。此外,扫描数量的增加与能够读取资料的放射科医生数量之间的差距日益扩大,是促进人工智慧在医学影像处理市场中采用的一个主要要素。
资料外洩和诈欺存取患者资料可能会阻碍人工智慧在医学影像行业的普及。对于市场参与企业来说,平衡资料可近性和隐私性是很困难的。此外,使用人工智慧进行医学影像处理需要遵守法规和法律要求。用于医疗用途的人工智慧演算法的开发和应用必须遵循管理机构和医疗设备主管机关制定的严格法规。这些方面都限制了市场的拓展。
COVID-19大流行对全球几乎所有行业都产生了重大影响,医疗保健除外。医疗保健领域开发人工智慧解决方案的主要领域是医学影像处理。由于 COVID-19 在感染疾病和肺部疾病影像中的广泛使用,许多医院放射科的使用量显着增加。疫情与对技术和数数位解决方案的需求增加之间存在很强的相关性。从中长期来看,COVID-19 技术的影响可能非常正面。
预计 X 光领域在预测期内将占据最大的市场占有率。由于其高精度,X 射线模式对人工智慧的需求不断增加。 X光影像与AR和VR技术的整合为放射科医生提供了身临其境型的互动体验。医疗保健专业人员现在可以查看三维 X 光影像,迭加解剖细节,甚至模拟术前计画的程序。此外,这些工具有助于更准确的解释、提高空间理解并加速片段进展。
在预测期内,乳房筛检领域预计将以最高成长率扩大。乳房筛检的需求是由于乳癌患者数量不断增加以及患者希望早期诊断以帮助他们尽快接受适当的治疗而推动的。此外,政府支持临床解读和扩大乳癌筛检技术的配合措施是预计推动细分市场扩张的两个关键因素。
由于技术先进的基础设施和高人均收入,预计北美将在 2022 年占据市场主导地位,并在预测期内继续占据主导地位。医疗影像处理市场中的人工智慧是由该地区众多市场参与者和有利的政府法规所推动的。该地区的研究和医疗机构也在人工智慧方面进行了大量投资。此外,主要行业参与者的强大影响力和蓬勃发展的医疗基础设施正在推动该地区的成长。
由于最尖端科技的普及、网路连接的改善以及政府配合措施的增加,预计亚太地区将呈现最高的成长率。投资的急剧增加、越来越多的新兴企业使用人工智慧(AI)(尤其是在中国和印度)以及人工智慧透过提高图像品质来缩小该地区医疗基础设施差距的巨大潜力都是进一步的推动因素。我是。这些技术还具有很高的临床价值,推动市场成长。
According to Stratistics MRC, the Global Artificial Intelligence (AI) in Medical Imaging Market is accounted for $1.77 billion in 2023 and is expected to reach $10.25 billion by 2030 growing at a CAGR of 28.5% during the forecast period. Artificial intelligence (AI) in medical imaging refers to the application of AI techniques to a variety of imaging modalities, including ultrasound, computed tomography (CT), magnetic resonance imaging (MRI), and X-rays, to improve and automate the processing of medical images. It involves analyzing and extracting significant information from medical images using sophisticated algorithms and machine learning models in order to aid in the recognition, diagnosis, and treatment of a variety of illnesses and ailments.
According to the American Cancer Society, a total of 236,740 new cases of lung and bronchus cancer are estimated this year in the United States.
The market for medical imaging is being driven by AI in the current scenario. This is because the software gives doctors a benefit by making it possible for them to diagnose illnesses much more quickly and enable earlier intervention. Additionally, new AI-driven start-ups are putting an emphasis on and adding sophisticated features to AI medical imaging solutions. To advance AI in medical imaging, it is also necessary to increase funding and investment in the field. For instance, Lithuania's oxipit.ai raised USD 4.9 million in funding in January 2023 to develop fully autonomous AI medical imaging and broaden the market in new regions. Thus, market growth is being driven by the rising number of AI-driven start-ups globally and the rising funding for the development of fully autonomous AI medical imaging tools.
The market's growth is constrained by the high cost of various artificial intelligence techniques used in medical imaging samples and other equipment for diagnosing many diseases. The majority of hospitals and research institutions in underdeveloped and developing nations are currently unable to afford the higher costs associated with the R&D of artificial intelligence in medical imaging. These factors thus inhibit market growth.
In the upcoming years, it is anticipated that advanced AI tools and technology will significantly change the healthcare and radiology industries. Companies involved in the current AI in the medical imaging industry anticipate that the adoption of AI in the medical field, particularly in radiology, will present a wide range of opportunities. Moreover, the growing disparity between the rising number of scans and the number of available radiologists who can read data is a major factor that will aid in the adoption of AI in the medical imaging market.
Data breaches or unauthorized access to patient data could hinder the widespread use of AI in the medical imaging industry. Finding a balance between data accessibility and privacy will be difficult for market participants. Additionally, AI must adhere to rules and legal requirements before it can be used in medical imaging. Strict regulations, such as those set forth by governing bodies and medical device authorities, must be followed in the development and application of AI algorithms for medical applications. Such aspects limit the market from expanding.
The COVID-19 pandemic has had a significant impact on nearly every industry worldwide, with the exception of healthcare. The primary area in the healthcare sector where AI-enabled solutions are being developed is medical imaging. Due to the widespread use of COVID-19 for imaging infectious and lung diseases, radiology has seen a significant increase in use in many hospitals. A strong correlation exists between the pandemic and the increased demand for technology and digital solutions. The impact of COVID-19 technology could be very positive in the medium to long term.
During the forecast period, the X-ray segment is anticipated to hold the largest market share. The demand for AI in X-ray modalities has increased due to its high accuracy. Radiologists can now experience immersive and interactive experiences thanks to the integration of AR and VR technologies with X-ray imaging. X-ray images can now be seen in three dimensions by medical professionals, who can also overlay anatomical details or simulate procedures for preoperative planning. Moreover, these tools can facilitate more accurate interpretations and improve spatial comprehension, which would accelerate segment progression.
It is anticipated that during the forecast period, the breast screening segment will expand at the highest rate. The demand for breast screening is being driven by the increase in breast cancer cases and patients' desires for an early-stage diagnosis, which aids in receiving the proper treatment as soon as possible. Furthermore, government initiatives that support clinical interpretation and expanded access to breast cancer screening technologies are two additional major factors that are anticipated to fuel segment expansion.
Due to the technologically sophisticated infrastructure and high per capita income, North America dominated the market in 2022 and is predicted to dominate over the forecast period. The market for AI in medical imaging is being driven by the presence of numerous market players and favorable government regulations in the area. In addition, the region's research organizations and healthcare institutions are making significant investments in AI. Furthermore, a strong presence of major industry players and a thriving healthcare infrastructure are fostering regional growth in this region.
Due to the widespread adoption of cutting-edge technologies, improved network connectivity, and expanded government initiatives, Asia Pacific is anticipated to experience the highest growth rate. The exponential growth in investment, the rise in artificial intelligence (AI)-using startups, particularly in China and India, and the enormous potential for AI to close the region's healthcare infrastructure gap by enhancing image quality are additional motivating factors. These technologies also have a high clinical value, which is promoting market growth.
Some of the key players in Artificial Intelligence (AI) in Medical Imaging market include: 1QB Information Technology, Agfa-Gevaert Group, Arterys Inc, AZmed, BenevolentAI, BioXcel, Therapeutics Inc, Butterfly Network, Caption Health, CellmatiQ, dentalXrai, Digital Diagnostics, EchoNous, Enlitic, Inc, GE Healthcare, Gleamer, HeartVista, IBM Watson Health, K Health, Koninklijke Philips, mPulse Mobile, Nanox Imaging, OrCam, Owkin Inc., Siemens Healthineers AG, Suki AI, Inc, Ultromics, Viz.ai, Inc, ZealthLife technologies Pte. Ltd and Zebra Medical Vision.
In October 2023, BioXcel Therapeutics, Inc., a biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience, today provided an update on recent developments with its late-stage clinical programs as well as its patent portfolio for IGALMI™ (dexmedetomidine) sublingual film. These developments include meetings scheduled with the U.S. Food and Drug Administration (FDA) to discuss the TRANQUILITY and SERENITY III clinical programs and the receipt of two Notices of Allowance (NOAs) from the U.S. Patent and Trademark Office to extend method of use patent protection for sublingual dexmedetomidine.
In August 2023, Butterfly Network, Inc. a digital health company transforming care through the power of portable, semiconductor-based ultrasound technology and intuitive software, announced the release of its software development kit (SDK) for use by third parties. The kit will allow developers to utilize Butterfly's platform to build custom applications that can be commercialized to Butterfly's customer base - the largest user network in handheld point-of-care ultrasound.1 The Company ultimately plans to open "Butterfly Garden," an AI Marketplace where new apps will be hosted for Butterfly users to discover and purchase the latest AI capabilities.
In April 2023, AGFA HealthCare, a leading provider of Enterprise Imaging solutions, is proud to announce that it has joined the Amazon Web Services (AWS) Partner Network (APN) to scale up the global availability of AGFA Enterprise Imaging (AGFA EI) VNA and XERO® Universal Viewer on the cloud. The APN is a global community of AWS Partners that leverage programs, expertise, and resources to build, market, and sell customer offerings.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.